OpenAI’s GPT-5.3-Codex expands Codex into a full agentic system, delivering faster performance, top benchmarks, and advanced cybersecurity capabilities.
Dan tested Codex 5.3 on Proof, a macOS markdown editor that he's been vibe coding that tracks the origin of every piece of text—whether it was written by a human or generated by AI—and lets users ...
A hands-on test of a simple concept that delivers unexpected results, explained clearly to show why it works and what makes it effective. #Experiment #UnexpectedResults #CreativeTesting Department of ...
Alzheimer’s disease affects millions worldwide—but confirming a diagnosis is far from simple. Doctors currently rely on costly brain scans or invasive spinal fluid tests to identify the ...
On Sunday, J. D. Vance was presented with the simplest moral test: denounce commentators who traffic in medieval blood libels, who deny the Holocaust, and who endlessly harp on evil Jewish cabals.
James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...
The Italian startup will use the investment to build proprietary AI models, accelerate global expansion, and hire new talent. Italian cybersecurity startup Equixly on Tuesday announced raising €10 ...
What if building advanced AI-powered search systems didn’t require a team of engineers or months of development? Imagine uploading a few files, tweaking minimal settings, and instantly allowing your ...
Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, India-based API maker, both linked to testing shortfalls. The letter comes in ...
Two doctors have shared a simple string test that can reveal a lot about your health. Dr Clare Bailey Mosley - the wife of the late Dr Michael Mosley - and their son, Dr Jack Mosley, shared a video on ...
More than 300,000 women are diagnosed with ovarian cancer globally each year. The four-year clinical trial across 15 Australian hospitals – known as SOLACE2 – was co-led by the University of Sydney ...